Correlation Between Guangzhou Baiyunshan and CanSino Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Guangzhou Baiyunshan and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guangzhou Baiyunshan and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guangzhou Baiyunshan Pharmaceutical and CanSino Biologics, you can compare the effects of market volatilities on Guangzhou Baiyunshan and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guangzhou Baiyunshan with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guangzhou Baiyunshan and CanSino Biologics.

Diversification Opportunities for Guangzhou Baiyunshan and CanSino Biologics

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Guangzhou and CanSino is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Guangzhou Baiyunshan Pharmaceu and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Guangzhou Baiyunshan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guangzhou Baiyunshan Pharmaceutical are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Guangzhou Baiyunshan i.e., Guangzhou Baiyunshan and CanSino Biologics go up and down completely randomly.

Pair Corralation between Guangzhou Baiyunshan and CanSino Biologics

Assuming the 90 days horizon Guangzhou Baiyunshan Pharmaceutical is expected to generate 0.37 times more return on investment than CanSino Biologics. However, Guangzhou Baiyunshan Pharmaceutical is 2.73 times less risky than CanSino Biologics. It trades about -0.17 of its potential returns per unit of risk. CanSino Biologics is currently generating about -0.23 per unit of risk. If you would invest  210.00  in Guangzhou Baiyunshan Pharmaceutical on October 15, 2024 and sell it today you would lose (6.00) from holding Guangzhou Baiyunshan Pharmaceutical or give up 2.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Guangzhou Baiyunshan Pharmaceu  vs.  CanSino Biologics

 Performance 
       Timeline  
Guangzhou Baiyunshan 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Guangzhou Baiyunshan Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Guangzhou Baiyunshan is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
CanSino Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, CanSino Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Guangzhou Baiyunshan and CanSino Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Guangzhou Baiyunshan and CanSino Biologics

The main advantage of trading using opposite Guangzhou Baiyunshan and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guangzhou Baiyunshan position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.
The idea behind Guangzhou Baiyunshan Pharmaceutical and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital